Last updated on: 14/03/2012
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: ASSR Emilia-Romagna
Name of data sourceEmilia Romagna Hospital Discharge
Name under which the data source should be displayed in the inventory (e.g short name if one exists) Hospital Discharge
Name of organisation
1) Department/research groupCeVEAS, Centre for the Evaluation of the Effectiveness of Health Care
2) Organisation/affiliationNHS (Local Health Authority, Modena)
Administrative Contact
Title Mrs
Last name Pozzessere
First name Cinzia
Address line 1Viale Muratori 201
Address line 2
Address line 3
CityModena
Postcode41124
CountryItaly
Scientific Contact
Title Dr
Last name Magrini
First name Nicola
Address line 1Viale Muratori 201
Address line 2
Address line 3
CityModena
Postcode41124
CountryItaly
Alternative Contact
Title Mr
Last name Formoso
First name Giulio
Address line 1Viale Muratori 201
Address line 2
Address line 3
CityModena
Postcode41124
CountryItaly
2. Description/category
Administrative database, e.g. claims database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
None
3.2 ATC code (5th level)
No
3.3 Other product dictionaries
No
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
Discharge diagnosis
Yes
ICD9
Death
No
Procedures
Yes
ICD9
5. Year of establishment
1994
6. Geographical origin of data
EEA/EFTA countries
Italy
7. Demographical extent of data collection
Regional sub-set :
EMILIA ROMAGNA NHS DATA
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
adolescents (12 to 17 years)
18 to 45 years
46 to 64 years
65 years and over
65 to 75 years
76 years and over
9. Size of the source/catchment population
3,950,000
10 a. Total (cumulative) number of persons with actual data
10 b. Number of persons with active data collection in past calendar year
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
Yes
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
Yes :
Record linkage through anonymous patient code to drug prescriptions data, outpatient procedures
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
Yes
15. Charge/fee for data access
No
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
De Palma R, Liberati A, Ciccone G, et al. Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system. J Clin Oncol. 2008;26:1033-9
Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med. 2007;147:553-62
Magrini N, Formoso G, Marata AM, et al. Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy. BMC Health Serv Res. 2007 Sep 28;7:158 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100051/
